Press-release for stocks for ucb s.a. for amgn

| -5.87% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $92.7 -2.18% 600K

| -3.13% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | News | $138.24 -4.19% 800

| 6.54% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | $93.6375 6.88% 82K

| -8.14% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $63.676 -4.38% 7.2K

| 25.87% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | $9.47 -1.11% 520K

| -16.01% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.24 0.61% 0.0% 1.3M

| -10.79% | O: -0.2% H: 0.14% C: -0.48%
NVS | $94.36 1.93% 0.0% 2.3M

| -9.24% | O: -0.06% H: 0.46% C: 0.29%
GSK | News | $39.75 1.22% 0.0% 1.6M

| -5.58% | O: -0.69% H: 1.42% C: 1.22%
LLY | News | $726.31 -2.63% -0.04% 3.5M

| 0.65% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.93 1.3% 0.0% 10M

| -5.13% | O: -0.65% H: 1.63% C: 1.48%
ABBV | $166.41 1.06% 0.0% 5.5M

| -6.33% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -3.44% | O: 1.67% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 4.88% | O: -2.81% H: 2.08% C: 1.38%
AMGN | $269.03 2.39% 2.33% 3.4M

| -6.54% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K

| -13.72% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | News | $138.24 -4.19% 800

| 1.09% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $63.676 -4.38% 7.2K

| 37.02% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | $9.47 -1.11% 520K

| -14.23% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M

| -7.13% | O: 0.07% H: 0.42% C: 0.07%
NVS | $94.36 1.93% 0.0% 2.3M

| -10.28% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $147.91 1.49% -0.03% 9.6M

| -6.93% | O: 1.47% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M

| 6.49% | O: 0.76% H: 4.31% C: 2.11%
BMY | $48.93 1.3% 0.0% 10M

| -1.95% | O: -0.14% H: 0.35% C: -1.12%
ABBV | $166.41 1.06% 0.0% 5.5M

| -3.43% | O: 1.48% H: 0.0% C: 0.0%
VRTX | News | $394.43 0.24% 0.24% 1.3M

| -5.09% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -2.19% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $109.96 0.63% 0.63% 760K

| -14.12% | O: -0.02% H: 0.0% C: -1.4%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 1.83% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $269.03 2.39% 2.33% 3.4M

| -16.18% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

Key Players Such as AbbVie, Roche, and Amgen Dominate the Competitive Landscape of the Expanding Cytokine Market
Published: 2023-11-03 (Crawled : 01:00) - prnewswire.com
UCBJF | $126.05 -39.66% 100

| 67.95% | O: -1.4% H: 0.0% C: 0.0%
UCBJY | $63.676 -4.38% 7.2K

| 74.86% | O: 0.48% H: 1.02% C: 0.42%
TMO | News | $544.78 0.6% 0.0% 1.7M

| 19.94% | O: 2.32% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M

| 16.94% | O: 1.88% H: 0.0% C: 0.0%
TECH | $62.12 -0.15% -0.14% 910K

| 13.21% | O: 2.71% H: 4.38% C: 3.18%
AMGN | $269.03 2.39% 2.33% 3.4M

| -0.62% | O: 0.72% H: 0.76% C: 0.5%
ABCM | $23.99 0.0% 7.4M

| 3.63% | O: 0.0% H: 0.0% C: 0.0%
market

Leading Players Pfizer, AbbVie, and Novartis at the Forefront of Advancements in Plaque Psoriasis Treatment
Published: 2023-09-20 (Crawled : 22:00) - prnewswire.com
UCBJY | $63.676 -4.38% 7.2K

| 41.78% | O: -0.79% H: 0.0% C: -1.26%
NVS | $94.36 1.93% 0.0% 2.3M

| -10.14% | O: -0.7% H: 0.06% C: -0.75%
LLY | News | $726.31 -2.63% -0.04% 3.5M

| 30.85% | O: -1.47% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M

| 7.43% | O: -0.04% H: 0.76% C: -0.16%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -17.87% | O: -1.16% H: 0.0% C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M

| -2.4% | O: 0.22% H: 0.15% C: -0.98%
psoriasis treatment novartis

Global Best Selling Pharmaceutical Drugs Analysis Report 2023: Revenue Forecast of the Top 50 Pharmaceutical Drugs and Assessment of their Regulatory Landscape through 2021
Published: 2023-03-10 (Crawled : 20:00) - prnewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M

| Email alert Add to watchlist
CSLLY | $86.918 3.3% 60K

| Email alert Add to watchlist
MNK | $0.3402 -0.06% 540K

| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M

| Email alert Add to watchlist
GLAXF | News | $20.2 -14.18% 510

| Email alert Add to watchlist
MNKPF | $17.25

| Email alert Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M

| Email alert Add to watchlist
ENDP | $0.2926 -9.6%

| Email alert Add to watchlist
ALPMY | $9.47 -1.11% 520K

| Email alert Add to watchlist
VTRS A | $11.25 1.17% 1.16% 4.7M

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K

| Email alert Add to watchlist
UCBJY | $63.676 -4.38% 7.2K

| Email alert Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M

| Email alert Add to watchlist
ALPMF | $9.17 43.47% 16K

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K

| Email alert Add to watchlist
BHC | $8.69 1.05% 0.0% 2.9M

| Email alert Add to watchlist
UCBJF | $126.05 -39.66% 100

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380

| Email alert Add to watchlist
ENDPQ | $0.0006 -50.0% 3.4K

| Email alert Add to watchlist
CMXHF | $172.54 -19.21% 50

| Email alert Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M

| Email alert Add to watchlist
MNKKQ | $0.02

| Email alert Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M

| Email alert Add to watchlist
NVO | News | $122.71 -0.03% 0.17% 5M

| Email alert Add to watchlist
global report

$121 Billion Worldwide Cytokine Industry to 2027 - Featuring AbbVie, Abcam, Amgen and Applied Biological Materials Among Others
Published: 2023-01-10 (Crawled : 12:00) - prnewswire.com
UCBJY | $63.676 -4.38% 7.2K

| 52.55% | O: -0.31% H: 0.5% C: 0.0%
TMO | News | $544.78 0.6% 0.0% 1.7M

| -2.4% | O: 0.25% H: 4.59% C: 3.76%
ABBV | $166.41 1.06% 0.0% 5.5M

| 2.17% | O: 0.35% H: 0.12% C: -1.6%
TECH | $62.12 -0.15% -0.14% 910K

| -25.27% | O: 1.02% H: 2.28% C: 2.05%
AMGN | $269.03 2.39% 2.33% 3.4M

| -1.92% | O: 0.68% H: 0.98% C: 0.71%
ABCM | $23.99 0.0% 7.4M

| 46.37% | O: -1.28% H: 2.9% C: 2.1%

Outlook on the Pharmaceutical Drugs Global Market to 2027: Look at the Changing Structure of the Pharma and Healthcare Industry
Published: 2023-01-03 (Crawled : 13:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 3.4K

| -94.35% | O: -1.13% H: 28.57% C: 19.0%
CSLLY | $86.918 3.3% 60K

| -9.95% | O: -3.93% H: 2.17% C: 1.75%
MNK | $0.3402 -0.06% 540K

| -94.75% | O: 3.1% H: 0.0% C: -2.75%
GLAXF | News | $20.2 -14.18% 510

| 15.53% | O: -0.2% H: 2.06% C: 2.06%
SNYNF | News | $92.7 -2.18% 600K

| -3.71% | O: 1.09% H: 0.54% C: 0.54%
UCBJY | $63.676 -4.38% 7.2K

| 63.03% | O: 1.0% H: 0.0% C: -0.26%
ALPMY | $9.47 -1.11% 520K

| -38.39% | O: 3.43% H: 0.0% C: -2.93%
VTRS A | $11.25 1.17% 1.16% 4.7M

| -0.09% | O: 0.54% H: 2.5% C: 1.7%
NVO | News | $122.71 -0.03% 0.17% 5M

| -7.99% | O: 1.43% H: 0.84% C: -0.23%
NVS | $94.36 1.93% 0.0% 2.3M

| 2.6% | O: 0.42% H: 1.35% C: 1.22%
JNJ | News | $147.91 1.49% -0.03% 9.6M

| -17.95% | O: -0.28% H: 1.26% C: 1.15%
GSK | News | $39.75 1.22% 0.0% 1.6M

| 12.69% | O: -0.57% H: 1.35% C: 1.0%
BHC | $8.69 1.05% 0.0% 2.9M

| 39.17% | O: 0.48% H: 3.96% C: -0.48%
ABBV | $166.41 1.06% 0.0% 5.5M

| 2.2% | O: 0.27% H: 0.6% C: 0.21%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -5.89% | O: 0.16% H: 0.0% C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M

| 0.87% | O: -0.67% H: 0.66% C: 0.3%
pharma global market

Disease-Modifying Antirheumatic Drug (DMARD) Market to Surpass US$ 27,167.8 Million by 2030 - Coherent Market Insights
Published: 2022-09-06 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

| 17.12% | O: -3.02% H: 0.0% C: 0.0%
UCBJY | $63.676 -4.38% 7.2K

| 86.52% | O: 0.73% H: 2.28% C: 1.72%
JNJ | News | $147.91 1.49% -0.03% 9.6M

| -11.61% | O: -0.65% H: 0.93% C: 0.71%
BMY | $48.93 1.3% 0.0% 10M

| -29.64% | O: 0.03% H: 1.18% C: 0.13%
ABBV | $166.41 1.06% 0.0% 5.5M

| 20.04% | O: -0.03% H: 1.08% C: 0.84%
SNY | News | $46.32 2.05% 2.01% 3.3M

| 14.25% | O: 0.49% H: 0.0% C: 0.0%
GILD | $66.77 0.92% 0.91% 11M

| 5.54% | O: 0.44% H: 2.03% C: 1.76%
CPIX | $1.65 6.02% 790

| -29.41% | O: -4.52% H: 7.12% C: 5.69%
AMGN | $269.03 2.39% 2.33% 3.4M

| 9.38% | O: 0.24% H: 1.04% C: 0.82%
drug market

Global Axial Spondyloarthritis Market Research Repoirt 2022: Biopharmaceutical Companies are Trying to Match Themselves with New Technologies in the Market to Improve the Overall System
Published: 2022-06-14 (Crawled : 11:00) - prnewswire.com
UCBJY | $63.676 -4.38% 7.2K

| 55.06% | O: -0.22% H: 0.0% C: -1.02%
TAK | News | $13.24 0.61% 0.0% 1.3M

| -0.98% | O: -0.04% H: 0.0% C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M

| -47.87% | O: -2.24% H: 0.0% C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M

| -14.89% | O: 0.43% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M

| 158.36% | O: -0.49% H: 0.98% C: 0.56%
BMY | $48.93 1.3% 0.0% 10M

| -34.58% | O: -0.4% H: 0.33% C: -0.91%
ABBV | $166.41 1.06% 0.0% 5.5M

| 17.22% | O: -1.04% H: 0.87% C: -1.31%
AMGN | $269.03 2.39% 2.33% 3.4M

| 11.35% | O: -0.41% H: 0.73% C: -0.54%
research system companies market

Global Lupus Therapeutic Market to Surpass US$ 5,408.1 Million by 2030, Says Coherent Market Insights
Published: 2022-03-16 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

| -3.16% | O: -0.46% H: 3.49% C: 3.49%
NVSEF | $93.6375 6.88% 82K

| 15.32% | O: 2.25% H: 0.0% C: 0.0%
UCBJY | $63.676 -4.38% 7.2K

| 16.13% | O: 1.41% H: 2.33% C: 0.04%
TAK | News | $13.24 0.61% 0.0% 1.3M

| -9.25% | O: 2.07% H: 1.62% C: 1.56%
NVS | $94.36 1.93% 0.0% 2.3M

| 10.49% | O: 0.74% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M

| -5.04% | O: 0.41% H: 0.0% C: 0.0%
BMY | $48.93 1.3% 0.0% 10M

| -30.75% | O: 0.26% H: 0.31% C: -0.39%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -11.53% | O: 0.82% H: 0.0% C: 0.0%
AUPH | $5.01 4.16% 3.99% 1.6M

| -54.15% | O: 0.95% H: 6.23% C: 5.19%
AMGN | $269.03 2.39% 2.33% 3.4M

| 14.41% | O: 0.41% H: 0.0% C: -0.37%
lupus market

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M

Finance

EGOX | $0.0515 43.06% 30.1% 330M

OLB 4 | $0.33 -14.95% 25.53% 840K

Technology Services

NVFY | $2.77 31.28% 23.83% 33M

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M

Distribution Services

INSG | $3.03 25.21% 20.13% 330K

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K